Allergan, Inc. (AGN), Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK) & The Week, Biotech
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
